Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Giancarlo Panelli"'
Autor:
A. Tortoriello, G. Facchini, G. Ferrante, Giancarlo Panelli, Paolo Muto, Francesco Caponigro, Rosario Vincenzo Iaffaioli
Publikováno v:
Drug Investigation. 7:209-214
We investigated the effects of thymostimulin (TST) vs placebo administration in a randomised trial performed in patients with locally advanced non-small-cell lung cancer treated with a combined modality programme that included hyperfractionated split
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6beac37b034e4a0950f3a3b7e800d010
https://doi.org/10.1007/bf03257412
https://doi.org/10.1007/bf03257412
Autor:
A. Pepe, Giancarlo Panelli, Roberto Manzo, Anna Morra, Paola Murino, Massimo Mammucari, Vincenzo Ravo, M. F. Giugliano, D. Borrelli, Paolo Muto
Publikováno v:
Journal of painpalliative care pharmacotherapy. 25(2)
Radiotherapy is crucial in the management of cancer patients in both the curative and palliative settings. However, patients often report pain both during positioning for, and execution of, radiotherapy and this may be a reason for interrupting the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::691939c5484341814ac9e0edf5321af4
https://pubmed.ncbi.nlm.nih.gov/21657859
https://pubmed.ncbi.nlm.nih.gov/21657859
Publikováno v:
Scopus-Elsevier
Purpose. Our aim is to demonstrate that a fractionated high-dose rate endobronchial brachytherapy (HDRBT) treatment is tolerable for patients with advanced (IIIA-IIIB) non-small cell lung cancer and gives an improvement of symptoms. Patients and Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a3599fd97e449ea507cad1395ea2a0a
https://pubmed.ncbi.nlm.nih.gov/10884499
https://pubmed.ncbi.nlm.nih.gov/10884499
Autor:
Paolo Muto, A. Tortoriello, G. Facchini, Giancarlo Panelli, G. Frasci, Vincenzo Ravo, Rosario Vincenzo Iaffaioli, Francesco Caponigro
Publikováno v:
ResearcherID
Europe PubMed Central
Europe PubMed Central
Hyperfractionated split course radiotherapy combined with carboplatin, etoposide and mitomycin C was administered to 76 patients with stage III non-small cell lung cancer. Grade 4 leukopenia occurred in 5 patients; 4 toxic deaths were observed. The o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee482e63b6eea7f3ee81512b55972030
https://doi.org/10.3892/ijo.4.3.577
https://doi.org/10.3892/ijo.4.3.577
Autor:
Paolo Muto, Ferdinando Salzano de Luna, Adele Frattolillo, Giacinto Turitto, Giancarlo Panelli, Carlo Paolo De Angelis, Annunziata Auriemma, Rosario Vincenzo Iaffaioli, Giampiero Cione
Publikováno v:
Scopus-Elsevier
UNLABELLED The purpose of this phase II trial was to assess tolerance and efficacy of the combination of radiation, fluorouracil and oxaliplatin as neoadjuvant treatment in locally advanced rectal cancer. Between March 2001 and August 2004 , 28 patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21d163e44e2eb007f937db170ac03588
https://doi.org/10.2741/1880
https://doi.org/10.2741/1880
Publikováno v:
Radiotherapy and Oncology. 31:S46
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::243b736d74246e14d862a55ddbcd9232
https://doi.org/10.1016/0167-8140(94)91196-7
https://doi.org/10.1016/0167-8140(94)91196-7
Autor:
Giancarlo Panelli, Vincenzo Ravo, Antonio Laudati, Anna Morra, Paola Murino, Giuseppe Panetti, Roberto Manzo, Paolo Muto, Agnese Prisco
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
Aims and background Radiotherapy has remarkable success rates for the cure of patients affected by glottic carcinoma; local control rates are similar to surgery with lower morbidity and better functional results. Our aim was to determine local-region
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b0181759e912264e4bd3ac225b9b748
http://www.scopus.com/inward/record.url?eid=2-s2.0-77957190008&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-77957190008&partnerID=MN8TOARS
